162 results on '"Luft, Thomas"'
Search Results
2. Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease
3. Pulmonale Manifestation hämatoonkologischer Erkrankungen und Therapien
4. The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature
5. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
6. Prehabilitative high-intensity interval training and resistance exercise in patients prior allogeneic stem cell transplantation
7. Data-driven grading of acute graft-versus-host disease
8. EASIX-1year and late mortality after allogeneic stem cell transplantation
9. IFNγ Causes Keratinocyte Necroptosis in Acute Graft-Versus-Host Disease
10. Nephrologische Komplikationen nach allogener SCT
11. Interleukin-12 and Interleukin-18 Associate with Chronic Graft-Versus-Host Disease but with Inverse Clinical Outcomes
12. Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT
13. Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST)
14. Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis
15. Statin‐based endothelial prophylaxis and outcome after allogeneic stem cell transplantation
16. Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
17. A Software Tool for the Graph-Based Visualization of Complex Relations Between Product Properties and Characteristics
18. Impact of Resistance Exercise and Nutritional Endorsement on physical performance in patients with GvHD (IRENE-G study) – design and rational of a randomized controlled trial
19. EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study
20. Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells
21. Response to Vaccination with Sars-CoV2 Vaccines in Patients Post Allogeneic Hematopoietic Cell Transplantation
22. Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation
23. Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation
24. Methoden der Entscheidungsfindung
25. Easix Predicts Severe Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neuro-Toxicity Syndrome (ICANS) in Patients Receiving CD19-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy
26. Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
27. Kynurenine Pathway Activation and Deviation in Fibrosing Chronic Graft-Versus-Host Disease
28. Easix before Conditioning Therapy Predicts Sepsis after Allogeneic Stem Cell Transplantation
29. Th22 and Tfh Cell Elevation Is Associated with Clinical Response of Photopheresis Therapy in Patients with Steroid-Refractory/ Resistant Graft-Versus-Host Disease (GvHD)
30. Kynurenine pathway activation and deviation to anthranilic and kynurenic acid in fibrosing chronic graft-versus-host disease
31. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT
32. Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation
33. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
34. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
35. A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation
36. Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD
37. Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
38. Variant Value Management to Optimize Complexity and Value of Product Families
39. Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia
40. An Indicator-Based Process Monitoring Cockpit for Controlling and Enhancing Product Development Processes – An Industrial Case Study
41. Enhancing the Flow of Information in the PLM by Using Numerical DSMs – An Industrial Case Study
42. CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison
43. Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile
44. Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
45. Easix As Prediction Score before CAR-T Cells Vs Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Relapsed/Refractory (r/r) Large B Cell Lymphoma (LBCL)
46. Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
47. The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis
48. Influencing factors of cardiorespiratory fitness in allogeneic stem cell transplant candidates prior to transplantation
49. Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT
50. High leukemia-free survival after TBI-based conditioning and mycophenolate mofetil-containing immunosuppression in patients allografted for chronic myelomonocytic leukemia: a single-center experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.